Epilepsy is incredibly complex, which makes collaboration between patients, clinicians, drug companies, technology companies, and others, essential for advancements in treatment.
Our beta program is actively enrolling select patients and clinicians in North America. We are also seeking investors, innovators, and partners to collaborate with on this important journey. Join us in making a difference for people living with epilepsy!
Complete the sign-up form and our team will respond as soon as possible.
By partnering with patient groups and prestigious institutions across the US and Canada, Novela fosters a collaborative environment to develop and improve upon our solutions.